[HTML][HTML] Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research

A Ahmad, NM Mubarak, K Naseem, H Tabassum… - Arabian Journal of …, 2020 - Elsevier
This review depicts the exposure of chitin and chitosan base multifunctional nanomaterial
composites for promising applications in field of biomedical science structure, synthesis as …

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

H Jamshaid, FU Din, GM Khan - Journal of Nanobiotechnology, 2021 - Springer
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and
mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …

Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses

S Batool, F Zahid, F Ud-Din, SS Naz… - Drug development …, 2021 - Taylor & Francis
Objective The purpose of this study was to develop novel carbopol-based miltefosine-
loaded transfersomal gel (HePCTG) for the treatment of cutaneous leishmaniasis (CL) via …

Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis

MM Khan, SS Zaidi, FJ Siyal, SU Khan, G Ishrat… - Journal of Drug Delivery …, 2023 - Elsevier
Topical drug delivery against cutaneous leishmaniasis (CL) serves as an effective alternate
approach to improve efficacy and reduce systemic adverse effects. The purpose of this study …

Nanoparticle drug conjugates treating microbial and viral infections: A review

S Gatadi, YV Madhavi, S Nanduri - Journal of molecular structure, 2021 - Elsevier
Rise in drug resistance to conventional antimicrobial agents has created major healthcare
threat and increased mortality risk globally. Some of the conventional antimicrobial agents …

Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti …

S Bashir, K Shabbir, F ud Din, SU Khan, Z Ali, BA Khan… - Heliyon, 2023 - cell.com
Purpose Anti-leishmanial medications administered by oral and parenteral routes are less
effective for treatment of cutaneous leishmaniasis (CL) and cause toxicity, hence targeted …

Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis

F Esfandiari, MH Motazedian, Q Asgari, MH Morowvat… - Acta tropica, 2019 - Elsevier
Cutaneous leishmaniasis is the most common form of leishmaniasis caused by different
species of Leishmania parasites. The emergence of resistance, toxicity, long term treatment …

An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis

CAB Nieva, AG Cid, AI Romero, MF García-Bustos… - Acta Tropica, 2021 - Elsevier
Abstract Leishmaniasis is a Neglected Tropical Diseases caused by protozoan parasites of
the genus Leishmania. It is a major health problem in many tropical and subtropical regions …

[HTML][HTML] Evaluation of a self-nanoemulsifying docetaxel delivery system

S Akhtartavan, M Karimi, K Karimian, N Azarpira… - Biomedicine & …, 2019 - Elsevier
A self-nanoemulsifying drug delivery system (SNEDDS) was developed as a novel route to
enhance the efficacy of docetaxel lipophilic drug. SNEDDS comprised ethyl oleate, Tween …

Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis

O Kammona, E Tsanaktsidou - International Journal of Pharmaceutics, 2021 - Elsevier
Leishmaniasis is a prevalent parasitic infection belonging to neglected tropical diseases. It is
caused by Leishmania protozoan parasites transmitted by sandflies and it is responsible for …